FDA-Approved RSV Vaccine Enabled by Work of UT Molecular Biologist
May 05, 2023
May 05, 2023
AUSTIN, Texas, May 5 (TNSres) -- The University of Texas issued the following news release:
The first-ever vaccine approved by the Food and Drug Administration to treat respiratory syncytial virus (RSV) uses research from a team that includes Jason McLellan, a professor of molecular biosciences at The University of Texas at Austin.
"This is one of the most important viral pathogens for which we still lacked a vaccine. This milestone also means a lot to me and Barne . . .
The first-ever vaccine approved by the Food and Drug Administration to treat respiratory syncytial virus (RSV) uses research from a team that includes Jason McLellan, a professor of molecular biosciences at The University of Texas at Austin.
"This is one of the most important viral pathogens for which we still lacked a vaccine. This milestone also means a lot to me and Barne . . .